Bybit puts its money and faith in BitDAO and pledges recurring contributions now that its integration with the L2 Arbitrum network is complete.

DAO, Investments, FundingRead More

You might also be interested in reading Skye Bioscience accelerates nimacimab clinical trial timeline with early enrollment and extended treatment period.